NYSE
$1.15
(1.47%)
Subscribe to get
AI Score
We recently published a list of 12 Best Affordable Stocks To Buy Right Now. In this article, we are...
AMGEN Inc (NASDAQ: AMGN) has a price-to-earnings ratio that is above its average at 35.61x. Opinions on the stock are mixed, with 10 analysts rating it as a “buy,” 4 as “overweight,” 16 as “ ...
Amgen Inc. (NASDAQ:AMGN – Free Report) – Investment analysts at Zacks Research cut their Q1 2025 earnings per share (EPS) estimates for shares of Amgen in a research note issued on Wednesday ...
We came across a bullish thesis on Amgen Inc. (AMGN) on Disruptive analytics’ Substack by Magnus Ofstad. In this article, we will summarize the bulls’...
Looking for reliable income in the stock market? You might want to consider the top Dogs of the Dow...
Amgen’s AMGN stock has declined 12.1% in the past month. Late last month, Amgen announced the...
Amgen Inc (AMGN, Financial), a leading biotechnology company, announced that it will participate in Citi's 2024 Global Healthcare Conference on December 5, 2024, at 9:30 a.m. ET. The event will ...
Amgen Inc (AMGN, Financial) has announced a significant $1 billion investment to establish a second drug substance manufacturing facility in Holly Springs, North Carolina. This expansion, announced ...
Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and...
Per Lilly, this is its single-largest manufacturing investment in the country outside its home...